Preparation method and application of (hetero) aryl trifluoromethyl tellurium ether compound
Through the reaction of (hetero)aryl salt and trifluoromethyl tellurium salt under light conditions, the problems of harsh preparation conditions and low yield of trifluoromethyl tellurium compounds in the prior art are solved, and a variety of biologically active molecules are realized The efficient preparation of the product provides a green synthetic strategy suitable for the development of anti-cancer drugs.
Patent Information
- Application Number
- CN202411086457.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-08
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2044-08-08
AI Technical Summary
The existing preparation methods for trifluoromethyltelluryl compounds have defects such as harsh reaction conditions, low yields, and narrow substrate range, making it difficult to achieve efficient preparation of trifluoromethyltelluryl compounds with complex structures.
(hetero)aryl salt and trifluoromethyl tellurium salt react under light conditions, and (hetero)aryl trifluoromethyl tellurium ether is obtained through simple steps, avoiding the use of transition metal catalysts and ligands, and realizing the Trifluoromethyltellurylation reaction of various biologically active molecules.
This method is simple to operate, safe and efficient, easy to purify the product, high yield, wide application range of substrates, and provides a novel, efficient and green synthetic strategy suitable for the preparation of trifluoromethyltellurium with biological activity and anti-cancer drugs. base compound.
Smart Images

Figure CN119039219A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of organic synthesis, and specifically relates to a preparation method and application of a (hetero)aryl trifluoromethyl tellurium ether compound. Background Art
[0002] Tellurium was discovered by Muller in 1782 and exists in trace amounts in the earth's crust. When trifluoromethyl is connected to tellurium, the strong electron-withdrawing effect of trifluoromethyl will significantly reduce the electron cloud density at the center of the tellurium atom. Compared with tellurium ethers without fluorine, the electrical properties of the tellurium atoms in tellurium ethers containing trifluoromethyl will change from partially negative to partially positive, thus making them exhibit different properties.
[0003] Currently, the known methods for preparing trifluoromethyl telluride are very limited and can be roughly divided into two categories: direct method and indirect method. There are two main indirect methods for preparing trifluoromethyl telluride: (1) Using ArTeTeAr as the starting material, first react with NaBH4 to prepare ArTeH, and then react with CF3I at -78 o C to room temperature to obtain the corresponding aryl trifluoromethyl telluride ether (J. Am. Chem. Soc. 1993, 115, 2156-2164); (2) ArTeTeAr is used as the raw material and reacts with TMSCF3 in acetonitrile at room temperature to 80 oC reaction to obtain the corresponding aryl trifluoromethyl telluride ether (Organometallics, 2017, 36, 3750-3757). There are only a few direct methods for preparing trifluoromethyltelluride compounds: (1) Using KTeCF3 as a trifluoromethyltelluride reagent to prepare trifluoromethyl telluride ethers through nucleophilic substitution reaction (Angew. Chem. Int. Ed. 2018, 57,1381-1385); (2) Using Me3SnTeCF3 as a trifluoromethyltelluride reagent to prepare aryl trifluoromethyl telluride ethers in acetonitrile at room temperature (J. Fluorine Chem. 1999, 94, 195-198); (3) Using [Me4N][TeCF3] as a trifluoromethyltelluride reagent to react with dichloromethane, iodomethane, and methyl 4-bromobutyrate to prepare the corresponding trifluoromethyltelluride substituted products (J.Fluorine Chem. 2004, 125, 1437-1440; Z. Anorg. Allg. Chem. 2012, 638, 580-588; Org. Biomol. Chem. 2015, 13, 7027-7033); (4) Using Pd catalyst, the trifluoromethyltellurylation reaction of [Me4N][TeCF3] to aromatic halides was achieved (Angew. Chem. Int. Ed. 2018, 57, 16903-16906); (5) Using Cu catalyst, the trifluoromethyltellurylation reaction of [Me4N][TeCF3] to aromatic boronic acids was achieved (iScience2022, 25, 105566); (6) Using NIS as an initiator, the trifluoromethyltellurylation reaction of [Me4N][TeCF3] to electron-rich indoles was achieved (ChemistrySelect 2023, 8, e202302350). The existing synthesis methods of trifluoromethyltellurium compounds have defects such as single reaction type, harsh conditions, special starting materials, low yield, narrow substrate range, etc. Therefore, it is still necessary to explore a method with mild reaction conditions, simple operation, safety and efficiency, and wide application range to prepare complex molecules containing trifluoromethyltellurium with diverse structures, which is of great significance for the later application of trifluoromethyltellurium compounds.
[0004] Among the few trifluoromethyltellurylating agents, trifluoromethyl tellurium salts, such as [Me4N][TeCF3], are considered to be the most promising trifluoromethyltellurylating agents. Currently, trifluoromethyltellurylating reactions of aryl halides, aryl boronic acids, and electron-rich indoles have been achieved using [Me4N][TeCF3] as a trifluoromethyltellurylating agent, but these reactions are difficult to selectively functionalize complex aromatics. In order to construct trifluoromethyltelluryl compounds with more complex and diverse structures, a new method based on [Me4N][TeCF3] needs to be explored. Summary of the invention
[0005] The purpose of the present invention is to overcome the above technical deficiencies, propose a preparation method and application of (hetero)aryl trifluoromethyl telluride compounds, and solve the technical problems of harsh preparation conditions, low yield and narrow substrate range of (hetero)aryl trifluoromethyl telluride compounds in the prior art.
[0006] In a first aspect, the present invention provides a method for preparing a (hetero)aryl trifluoromethyl tellurium ether compound, comprising the following steps: The (hetero)aryl trifluoromethyl tellurium salt and the first solvent are reacted under light conditions, and after the reaction is completed, the (hetero)aryl trifluoromethyl tellurium ether is obtained by first separation and purification.
[0007] In a second aspect, the present invention provides the use of the preparation method of the above-mentioned (hetero)aryl trifluoromethyl telluride compounds in the preparation of drugs having a (hetero)aryl trifluoromethyl telluride structure.
[0008] Compared with the prior art, the beneficial effects of the present invention include: The present invention uses (hetero)aryl coronium salts and trifluoromethyltellurium salts as raw materials, and can achieve trifluoromethyltellurylation of various types of bioactive molecules under very mild reaction conditions without adding transition metal catalysts and ligands. The reaction is simple to operate, safe and efficient, the product is easy to purify, the yield is high, the substrate has a wide range of applications, good functional group tolerance, and the raw materials are cheap and easy to obtain, providing a novel, efficient and green strategy for synthesizing bioactive molecules containing trifluoromethyltellurium. BRIEF DESCRIPTION OF THE DRAWINGS
[0009] Figure 1 is the survival rate of Hela cells of Fenofibrate-TeCF3 prepared by the present invention at different drug concentrations; Figure 2 is the survival rate of Hela cells at different drug concentrations of Methyl Flurbiprofen-TeCF3 prepared by the present invention; Figure 3 is the Hela cell survival rate of Etofenprox-TeCF3 prepared by the present invention at different drug concentrations; Figure 4 is the Hela cell survival rate of Aniracetam-TeCF3 prepared by the present invention at different drug concentrations; Figure 5 is the Hela cell survival rate of Clofibrate-TeCF3 prepared by the present invention at different drug concentrations; Figure 6 is the Hela cell survival rate of Boscalid-TeCF3 prepared by the present invention at different drug concentrations; Figure 7 It is the survival rate of Hela cells of Pyriproxfen-TeCF3 prepared by the present invention at different drug concentrations. DETAILED DESCRIPTION
[0010] In order to make the purpose, technical solution and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not intended to limit the present invention.
[0011] In a first aspect, the present invention provides a method for preparing a (hetero)aryl trifluoromethyl tellurium ether compound, comprising the following steps: The (hetero)aryl coronium salt, trifluoromethyl tellurium salt and the first solvent are reacted under light conditions, and after the reaction is completed, the (hetero)aryl trifluoromethyl tellurium ether compound is obtained by first separation and purification; the reaction formula is as follows: ; In the formula, R 1 and R 2 are phenyl, and R 1 and R 2 The ends of the ring are not connected, or are directly connected to form a ring, or are connected to form a ring by -O-, or are connected to form a ring by -S-; Ar is one of substituted or unsubstituted phenyl, pyridyl, xanthanone, indolyl, benzothienyl and thienyl, and the substituent includes at least one of alkyl, alkoxy, phenoxy, ester, cyano, halogen, ketocarbonyl, amide, cyclic amide, sulfonamide and imide.
[0012] In the reaction system of the present invention, only aryl coronium salt, trifluoromethyl tellurium salt and solvent need to be added to achieve trifluoromethyl tellurylation reaction of various types of bioactive molecules. At the same time, the reaction system has the advantages of simple raw material source, low cost, mild reaction conditions, simple operation, good functional group tolerance and environmental friendliness.
[0013] In this embodiment, the (hetero)aryl coronium salt is one of a thianthrene coronium salt containing a (hetero)aryl group, a phenoxathiol coronium salt containing a (hetero)aryl group, a dibenzothiophene coronium salt containing a (hetero)aryl group, and a diphenyl coronium salt containing a (hetero)aryl group.
[0014] Preferably, the (hetero)aryl coronium salt is a thianthrene coronium salt containing a (hetero)aryl group, and the reaction formula involved in the preparation method of the (hetero)aryl trifluoromethyl tellurium ether compound is as follows: .
[0015] In some specific embodiments of the present invention, the preparation method of the thianthrene-based coronium salt containing a (hetero)aryl group comprises the following steps: The (hetero)aromatic hydrocarbon, thianthrene oxide, acid anhydride and optional acid are reacted in a second solvent, and after the reaction is completed, a second separation and purification is performed to obtain a thianthrene-based thianthrene salt containing a (hetero)aromatic group; the reaction formula is as follows: .
[0016] Preferably, the acid anhydride is at least one of trifluoromethanesulfonic anhydride or trifluoroacetic anhydride.
[0017] Preferably, the acid is trifluoromethanesulfonic acid.
[0018] Preferably, the molar ratio of (hetero)aromatic hydrocarbon to thianthrene oxide is 1:(0.1-10), including but not limited to 1:0.1, 1:0.5, 1:1, 1:1.5, 1:2, 1:4, 1:6, 1:8, 1:10, etc.
[0019] Preferably, the usage ratio of the (hetero)aromatic hydrocarbon to the total amount of the acid and the acid anhydride is (1-6) mol:1 L, including but not limited to 1 mol:1 L, 2 mol:1 L, 3 mol:1 L, 4 mol:1 L, 5 mol:1 L, 6 mol:1 L, etc.
[0020] Preferably, the usage ratio of the (hetero)aromatic hydrocarbon to the second solvent is (0.05-0.3) mol:1 L, including but not limited to 0.05 mol:1 L, 0.1 mol:1 L, 0.15 mol:1 L, 0.2 mol:1 L, 0.25 mol:1 L, 0.3 mol:1 L, etc.
[0021] Preferably, the second solvent is one of acetonitrile or dichloromethane.
[0022] Preferably, a mixture of (hetero)arene, thianthrene oxide, a second solvent, an acid anhydride and an optional acid is firstly heated at -50 to -40 o C for 0.5-2 hours, then warm to room temperature for 8-24 hours.
[0023] Preferably, the second separation and purification method includes at least one of extraction, washing, column chromatography and recrystallization.
[0024] Wherein, washing comprises at least one of water washing or washing with a saturated sodium trifluoromethanesulfonate aqueous solution.
[0025] Wherein, the extractant is at least one of dichloromethane or acetonitrile.
[0026] The eluent used for column chromatography is a mixed solvent of dichloromethane and acetonitrile, and the volume ratio of dichloromethane to acetonitrile is (1-5):1, including but not limited to 1:1, 2:1, 3:1, 4:1, 5:1, etc.
[0027] Wherein, the recrystallization solvent is a mixed solvent of dichloromethane and methyl tert-butyl ether, and the volume ratio of dichloromethane to methyl tert-butyl ether is 1:(10-25), including but not limited to 1:10, 1:15, 1:20, 1:25, etc.
[0028] In some more specific embodiments of the present invention, the preparation method of the thianthrene-based coronium salt containing a (hetero)aryl group comprises the following steps: In a protective atmosphere, add aromatic hydrocarbon or heteroaromatic hydrocarbon, thianthrene oxide and second solvent to the reaction vessel in sequence, cool to -50 ~ -40 o C, followed by the addition of anhydride and optionally acid at -50 ~ -40 o C for 0.5-2 hours, then warm to room temperature for 8-24 hours; after the reaction is completed, dilute the reaction solution with a diluent, then neutralize with a saturated sodium bicarbonate aqueous solution, wash the organic layer with water, and extract the aqueous layer with an extractant; after the organic layers are combined, the organic layers can be optionally washed with a saturated sodium trifluoromethanesulfonate aqueous solution, then dried with anhydrous sodium sulfate, and the excess solvent is removed under reduced pressure, and finally column chromatography or recrystallization is performed to obtain a thianthrene-containing (hetero)aryl salt of thianthrene. The diluent is at least one of dichloromethane and acetonitrile.
[0029] In this embodiment, the trifluoromethyl tellurium salt is [Me4N][TeCF3] (ie, trifluoromethyl tellurium tetramethyl ammonium salt), [ n -Bu4N][TeCF3], [PNP][TeCF3] and [(dibenzo-18-crown-6)K][TeCF3].
[0030] In this embodiment, the first solvent is one of N,N-dimethylformamide, dimethyl carbonate, acetonitrile, N,N-dimethylacetamide, tetrahydrofuran, n-hexane, ethyl acetate, 1,2-dichloroethane, diethylene glycol dimethyl ether, ethyl ether, methyl tert-butyl ether, dichloromethane, N-methylpyrrolidone, 1,4-dioxane, hexafluoroisopropanol, benzene, toluene, and xylene, preferably N,N-dimethylformamide.
[0031] In this embodiment, the molar ratio of the (hetero)aryl saponium salt to the trifluoromethyltellurium salt is 1:(0.5-3), including but not limited to 1:0.5, 1:1, 1:1.4, 1:2, 1:2.5, 1:3, etc.
[0032] In this embodiment, the usage ratio of the (hetero)arylstephonium salt to the first solvent is (0.025-0.3) mol: 1 L, including but not limited to 0.025 mol: 1 L, 0.05 mol: 1 L, 0.075 mol: 1 L, 0.1 mol: 1 L, 0.125 mol: 1 L, 0.15 mol: 1 L, 0.175 mol: 1 L, 0.2 mol: 1 L, 0.225 mol: 1 L, 0.25 mol: 1 L, 0.275 mol: 1 L, 0.3 mol: 1 L, etc.
[0033] In this embodiment, the wavelength of the light source used in the illumination conditions is 365-600 nm, including but not limited to 365-370 nm, 380-385 nm, 395-400 nm, 460-465 nm, blue LED (450-495 nm), and green LED (520-570 nm); the power is 5-50 W, including but not limited to 5 W, 10 W, 15 W, 20 W, 25 W, 30 W, 35 W, 40 W, 45 W, and 50 W.
[0034] In this embodiment, the reaction temperature is -40 ~ 40 o C, including but not limited to -40 o C. -30 o C. -20 o C. -10 o C. 0 o C. 10 o C. 20 o C. 30 o C. 40 o C, etc.; the time is 4-24 hours, including but not limited to 4 h, 8 h, 12 h, 16 h, 20 h, 24 h, etc.
[0035] In this embodiment, the process of reacting the (hetero)aryl coronium salt, the trifluoromethyl tellurium salt and the first solvent under light conditions is carried out under a protective atmosphere. The present invention does not limit the type of protective atmosphere, and those skilled in the art can select it according to actual conditions. For example, the protective atmosphere can be nitrogen, etc.
[0036] In this embodiment, the first separation and purification method includes: column chromatography.
[0037] Preferably, in the first separation and purification process, the eluent used for column chromatography is at least one of petroleum ether or ethyl acetate.
[0038] In this embodiment, the structural formula of the (hetero)aryl trifluoromethyl tellurium ether compound is selected from but not limited to one of the following:
[0039] .
[0040] In a second aspect, the present invention provides the use of the preparation method of the above-mentioned (hetero)aryl trifluoromethyl telluride compounds in the preparation of drugs having a (hetero)aryl trifluoromethyl telluride structure.
[0041] In this embodiment, the drug is an anticancer drug. The (hetero)aryl trifluoromethyl tellurium ether compounds of the present invention have high inhibitory activity against cancer cells and can be used to prepare anticancer drugs.
[0042] Furthermore, the cancer is cervical cancer. The present invention conducts biological activity evaluation on the above-mentioned synthesized trifluoromethyltellurium-containing compounds, and the results show that such compounds have high inhibitory activity against cervical cancer cells.
[0043] Unless otherwise specified, the raw materials, reagents or devices used in the following examples can be obtained from conventional commercial sources or by existing known methods.
[0044] Example 1
[0045] Step 1: Under nitrogen protection, 1-cyano-4-phenoxybenzene (5.2 mmol, 1.0 g), thianthrene oxide (5.2 mmol, 1.2 g) and DCM (20 mL) were added to a 25 mL round-bottom flask in sequence and the temperature was lowered to -40 o C, then trifluoromethanesulfonic anhydride (1 mL) was added and the mixture was heated at -40 oC for 1 hour, then warm to room temperature for 12 hours. After the reaction is completed, dilute the reaction solution with DCM (20 mL), neutralize with saturated sodium bicarbonate aqueous solution (40 mL), wash the organic layer with water (40 mL) once, extract the water layer with DCM (40 mL) twice, combine the organic layers and dry with anhydrous sodium sulfate, and remove excess solvent under reduced pressure. The residue is recrystallized with a mixed solvent of dichloromethane and methyl tert-butyl ether (1:25, 50 mL) to obtain the corresponding thorium salt (white solid, 2.1 g, 73%).
[0046] Step 2: In a glove box, 1-cyano-4-phenoxybenzthianthrene (0.1 mmol, 56.0 mg), [Me4N][TeCF3] (0.14 mmol, 37.9 mg) and DMF (0.5 mL) were added to a 10 mL reaction tube in sequence. The reaction temperature was controlled at 30-32 o C. The reaction tube was removed from the glove box and irradiated with a green LED (520-570 nm, 5 W) for 12 hours. After the reaction, the product was separated and purified by silica gel column chromatography using petroleum ether / ethyl acetate (20:1) as the eluent to obtain trifluoromethyltellurium-modified 1-cyano-4-phenoxybenzene molecule (light yellow oily liquid 32.5 mg, yield 83%). 1 H NMR (500 MHz, CDCl3) δ 8.02 (d, J = 8.46 Hz, 2H), 7.65 (d, J = 8.74Hz, 2H), 7.08 (d, J = 8.72 Hz, 2H), 7.01 (d, J = 8.49 Hz, 2H). 19 F NMR (471MHz, CDCl3) δ -25.7 (s, 3F). 13 C NMR (126 MHz, CDCl3) δ 160.5, 157.4, 144.0,134.5, 121.4, 119.1, 118.7, 107.2, 104.3, 100.1 (q, J = 354.7 Hz).
[0047] Example 2
[0048] Step 1: Under nitrogen protection, 1-cyano-4-phenoxybenzene (5.2 mmol, 1.0 g), thianthrene oxide (5.2 mmol, 1.2 g) and DCM (20 mL) were added to a 25 mL round-bottom flask in sequence and the temperature was lowered to -40o C, then trifluoromethanesulfonic anhydride (1 mL) was added, and the mixture was heated at -40 o C for 1 hour, then warm to room temperature for 12 hours. After the reaction is completed, dilute the reaction solution with DCM (20 mL), neutralize with saturated sodium bicarbonate aqueous solution (40 mL), wash the organic layer with water (40 mL) once, extract the aqueous layer with DCM (40 mL) twice, combine the organic layers and dry with anhydrous sodium sulfate, and remove excess solvent under reduced pressure. The residue is recrystallized with a mixed solvent of dichloromethane and methyl tert-butyl ether (1:25, 50 mL) to obtain the corresponding thorium salt (white solid, 2.1 g, 73%).
[0049] Step 2: In a glove box, add 1-cyano-4-phenoxybenzthianthrene (0.1 mmol, 56.0 mg), [Me4N][TeCF3] (0.14 mmol, 37.9 mg) and DMF (0.5 mL) to a 10 mL reaction tube. Remove the reaction tube from the glove box and irradiate it at 365-370 nm (5 W), 380-385 nm (5 W), 395-400 nm (5 W), 460-465 nm (5 W), and blue LED (450-495 nm, 5 W) for 12 hours. The reaction temperature is controlled at 30-32 o C. After the reaction, the product was separated and purified by silica gel column chromatography using petroleum ether / ethyl acetate (20:1) as the eluent to obtain trifluoromethyltelluryl-modified 1-cyano-4-phenoxybenzene molecules (yields were 72%, 65%, 67%, 76%, 73%, respectively). 1 H NMR (500 MHz, CDCl3) δ 8.02 (d, J = 8.46 Hz, 2H), 7.65 (d, J =8.74 Hz, 2H), 7.08 (d, J = 8.72 Hz, 2H), 7.01 (d, J = 8.49 Hz, 2H). 19 F NMR (471 MHz, CDCl3) δ -25.7 (s, 3F). 13 C NMR (126 MHz, CDCl3) δ 160.5, 157.4, 144.0, 134.5, 121.4, 119.1, 118.7, 107.2, 104.3, 100.1 (q, J = 354.7 Hz).
[0050] Example 3
[0051] Step 1: Under nitrogen protection, pyriproxyfen (1 mmol, 321.4 mg), thianthrene oxide (1 mmol, 232.3 mg) and acetonitrile (5 mL) were added to a 25 mL round-bottom flask in sequence and the temperature was lowered to -40 o C, trifluoroacetic anhydride (0.42 mL) and trifluoromethanesulfonic acid (0.26 mL) were added in sequence, and the mixture was stirred at -40 o C for 1 hour, then warm to room temperature for 12 hours. After the reaction is completed, dilute the reaction solution with DCM (20 mL), neutralize with saturated sodium bicarbonate aqueous solution (20 mL), wash the organic layer with water (20 mL) once, extract the water layer with DCM (20 mL) twice, combine the organic layers and wash twice with saturated sodium trifluoromethanesulfonate aqueous solution (20 mL), dry the organic phase with anhydrous sodium sulfate, and remove excess solvent under reduced pressure. The residue is recrystallized with a mixed solvent of dichloromethane and methyl tert-butyl ether (1:15, 50 mL) to obtain the corresponding thrombium salt (white solid, 388.8 mg, 57%).
[0052] Step 2: In a glove box, add pyriproxyfenthione thianthrene salt (0.1 mmol, 68.6 mg), [PNP][TeCF3] (0.14 mmol, 104.9 mg) and DMAc (0.5 mL) to a 10 mL reaction tube. Remove the reaction tube from the glove box and place it under green LED (520-570 nm, 5 W) for 12 hours. The reaction temperature is controlled at 30-32 o C. After the reaction, the product was separated and purified by silica gel column chromatography using petroleum ether / ethyl acetate (20:1) as the eluent to obtain the trifluoromethyltelluryl-modified pyriproxyfen molecule (light yellow oily liquid 30.1 mg, yield 58%). 1 H NMR (500MHz, CDCl3) δ 8.16-8.15 (m, 1H), 7.89 (d, J = 8.75 Hz, 2H), 7.57 (td, J =7.48 Hz, J = 1.93 Hz, 1H), 6.98 (q, J =9.15 Hz, 4H), 6.86 (d, J = 8.47 Hz, 3H), 6.76 (d, J = 8.29 Hz, 1H), 5.63-5.57 (m, 1H), 4.22-4.07 (m, 2H), 1.49 (d, J = 6.41 Hz, 3H).19 F NMR (471 MHz, CDCl3) δ -26.2 (s, 3F). 13 C NMR (126 MHz, CDCl3) δ 163.3, 160.9, 156.1, 148.9, 146.9, 143.7, 138.9, 121.7, 118.6,116.9, 116.1, 111.8, 101.3, 102.7 (q, J = 353.7 Hz), 71.2, 69.3, 17.1.
[0053] Example 4
[0054] Step 1: Under nitrogen protection, add methylflurbiprofen (MethylFlurbiprofen, 1 mmol, 258.3 mg), thianthrene oxide (1 mmol, 232.3 mg) and acetonitrile (5 mL) into a 25 mL round-bottom flask in sequence and cool to -40 o C, trifluoroacetic anhydride (0.42 mL) and trifluoromethanesulfonic acid (0.26 mL) were added, and the mixture was stirred at -40 o C for 1 hour, then warm to room temperature for 12 hours. After the reaction is completed, dilute the reaction solution with DCM (20 mL), neutralize with saturated sodium bicarbonate aqueous solution (20 mL), wash the organic layer with water (20 mL) once, extract the water layer with DCM (20 mL) twice, combine the organic layers and wash twice with saturated sodium trifluoromethanesulfonate aqueous solution (20 mL), dry the organic phase with anhydrous sodium sulfate, and remove excess solvent under reduced pressure. The residue is recrystallized with a mixed solvent of dichloromethane and methyl tert-butyl ether (1:25, 50 mL) to obtain the corresponding thrombium salt (white solid, 335.6 mg, 54%).
[0055] Step 2: In a glove box, add flurbiprofen thianthrene methyl salt (0.1mmol, 62.3mg), [(dibenzo-18-crown-6)K][TeCF3] (0.14mmol, 83.5mg) and DMF (0.5mL) to a 10mL reaction tube. Remove the reaction tube from the glove box and place it under green LED (520-570nm, 5W) for 12 hours. The reaction temperature is controlled at 30-32 oC. After the reaction was completed, the product was separated and purified by silica gel column chromatography using petroleum ether / ethyl acetate (10:1) as the eluent to obtain trifluoromethyltellurium-modified methylflurbiprofen molecule (light yellow oily liquid 30.0 mg, yield 66%). 1 H NMR (500 MHz, CDCl3) δ 8.05 (d, J = 8.00 Hz, 2H), 7.51 (d,J = 7.13 Hz, 2H), 7.39 (t, J =8.01 Hz, 1H), 7.18-7.13 (m, 2H), 3.77 (q, J =7.28 Hz, 1H), 3.71 (s, 3H), 1.55 (d, J = 7.14 Hz, 3H). 19 F NMR (471 MHz, CDCl3)δ -25.3 (s, 3F), -117.2 (m, 1F). 13 C NMR (126 MHz, CDCl3) δ 174.3, 159.7 (d, J= 249.3 Hz), 142.7 (d, J = 7.7 Hz), 141.5, 137.5, 130.7 (d, J = 7.7 Hz), 130.3 (d, J = 3.1 Hz), 126.6 (d, J = 13.3 Hz), 123.8 (d, J = 3.3 Hz), 115.4 (d, J = 23.5 Hz), 109.0, 102.8 (q, J = 354.3 Hz), 52.3, 45.0, 18.4.
[0056] Example 5
[0057] Step 1: Under nitrogen protection, add ethoxyfenprox (1 mmol, 376.5 mg), thianthrene oxide (1 mmol, 232.3 mg) and acetonitrile (5 mL) into a 25 mL round-bottom flask in sequence and cool to -40 o C, trifluoroacetic anhydride (0.42 mL) and trifluoromethanesulfonic acid (0.26 mL) were added in sequence, and the mixture was stirred at -40 oC for 1 hour, then warm to room temperature for 12 hours. After the reaction is completed, dilute the reaction solution with DCM (20 mL), neutralize with saturated sodium bicarbonate aqueous solution (20 mL), wash the organic layer with water (20 mL) once, extract the aqueous layer with DCM (20 mL) twice, combine the organic layers and wash twice with saturated sodium trifluoromethanesulfonate aqueous solution (20 mL), dry the organic phase with anhydrous sodium sulfate, and remove excess solvent under reduced pressure. The residue is separated by column chromatography using dichloromethane / acetonitrile (3:1) as the eluent to obtain the corresponding coronium salt (white solid, 592.7 mg, 80%).
[0058] Step 2: In a glove box, add thiophenethrin thianthrin salt (0.1 mmol, 74.1 mg), [n-Bu4N][TeCF3] (0.14 mmol, 61.8 mg) and DMF (0.5 mL) to a 10 mL reaction tube. Remove the reaction tube from the glove box and place it under green LED (520-570 nm, 5 W) for 12 hours. The reaction temperature is controlled at 30-32 o C. After the reaction was completed, the product was separated and purified by silica gel column chromatography using petroleum ether / ethyl acetate (10:1) as the eluent to obtain trifluoromethyltellurium-modified ethoxythrin molecule (light yellow oily liquid 37.0 mg, yield 50%). 1 H NMR(500 MHz, CDCl3) δ 7.73 (d, J = 2.08 Hz, 1H), 7.35-7.32 (m, 3H), 7.29-7.26(m, 2H), 7.11 (t, J = 7.39 Hz, 1H), 7.01 (d, J = 7.97 Hz, 2H), 6.93-6.89 (m,2H), 6.79 (d, J = 8.60 Hz, 1H), 4.45 (s, 2H), 4.07 (q, J = 6.91 Hz, 2H), 3.42(s, 2H), 1.41 (t, J = 6.95 Hz, 3H), 1.31 (s, 6H). 19 F NMR (471 MHz, CDCl3) δ -24.8 (s, 3F). 13C NMR (126 MHz, CDCl3) δ 157.5, 157.4, 156.4, 142.2, 141.0,135.3, 129.9, 128.5, 127.2, 123.4, 122.2, 119.1, 117.9, 117.8, 114.1, 110.9, 103.6 (q, J = 352.9 Hz), 80.1, 72.9, 65.0, 38.8, 26.3, 14.9.
[0059] Example 6
[0060] Step 1: Under nitrogen protection, fenofibrate (1 mmol, 360.8 mg), thianthrene oxide (1 mmol, 232.3 mg) and DCM (5 mL) were added to a 25 mL round-bottom flask in sequence and the temperature was lowered to -40 o C, then trifluoromethanesulfonic anhydride (0.2 mL) was added, and the mixture was stirred at -40 o C for 1 hour, then warm to room temperature for 12 hours. After the reaction is completed, dilute the reaction solution with DCM (20 mL), neutralize with saturated sodium bicarbonate aqueous solution (20 mL), wash the organic layer with water (20 mL) once, extract the water layer with DCM (20 mL) twice, combine the organic layers and dry with anhydrous sodium sulfate, and remove excess solvent under reduced pressure. The residue is recrystallized with a mixed solvent of dichloromethane and methyl tert-butyl ether (1:15, 50 mL) to obtain the corresponding thrombium salt (white solid, 300.0 mg, 41%).
[0061] Step 2: In a glove box, add fenofibrate thianthrene salt (0.1 mmol, 72.5 mg), [Me4N][TeCF3] (0.14 mmol, 37.9 mg) and DMAc (0.5 mL) to a 10 mL reaction tube. Remove the reaction tube from the glove box and place it under green LED (520-570 nm, 5 W) for 12 hours. The reaction temperature is controlled at 30-32 o C. After the reaction, the product was separated and purified by silica gel column chromatography using petroleum ether / ethyl acetate (10:1) as the eluent to obtain trifluoromethyltelluryl-modified fenofibrate molecule (45.6 mg of light yellow oily liquid, 82% yield). 1H NMR (500MHz, CDCl3) δ 8.19 (s, 1H), 7.75-7,70 (m, 3H), 7.46 (d, J =8.42 Hz, 2H), 6.79(d, J = 8.64 Hz, 1H), 5.11-5.05 (m, 1H), 1.69 (s, 6H), 1.20 (d, J = 6.32 Hz,6H). 19 F NMR (471 MHz, CDCl3) δ -24.8 (s, 3F). 13 C NMR (126 MHz, CDCl3) δ 193.4,172.3, 158.7, 139.7, 139.0, 135.8, 132.5, 132.4, 131.4, 128.8, 117.4, 114.2,104.2 (q, J = 353.6 Hz), 81.6, 69.9, 25.4, 21.6.
[0062] Example 7
[0063] Step 1: Under nitrogen protection, clofibrate (1 mmol, 242.7 mg), thianthrene oxide (1 mmol, 232.3 mg) and DCM (5 mL) were added to a 25 mL round-bottom flask in sequence and the temperature was lowered to -40 o C, then trifluoromethanesulfonic anhydride (0.2 mL) was added, and the mixture was stirred at -40 o C for 1 hour, then warm to room temperature for 12 hours. After the reaction is completed, dilute the reaction solution with DCM (20 mL), neutralize with saturated sodium bicarbonate aqueous solution (20 mL), wash the organic layer with water (20 mL) once, extract the aqueous layer with DCM (20 mL) twice, combine the organic layers and dry with anhydrous sodium sulfate, and remove excess solvent under reduced pressure. The residue is recrystallized with a mixed solvent of dichloromethane and methyl tert-butyl ether (1:10, 50 mL) to obtain the corresponding thrombium salt (white solid, 436.0 mg, 72%).
[0064] Step 2: In a glove box, add thianthrene clofibrate (0.1 mmol, 60.7 mg), [Me4N][TeCF3] (0.14 mmol, 37.9 mg) and THF (0.5 mL) to a 10 mL reaction tube. Remove the reaction tube from the glove box and place it under green LED (520-570 nm, 5 W) for 12 hours. The reaction temperature is controlled at 30-32 o C. After the reaction was completed, the product was separated and purified by silica gel column chromatography using petroleum ether / ethyl acetate (20:1) as the eluent to obtain trifluoromethyltellurium-modified clofibrate molecule (pale yellow oily liquid 40.2 mg, yield 92%). 1 H NMR (500MHz, CDCl3) δ 7.62 (d, J = 2.35 Hz, 1H), 7.18 (dd, J =8.77 Hz, J =2.45 Hz, 1H), 6.67 (d, J = 8.80 Hz, 1H), 4.23 (q, J =7.13 Hz, 2H), 1.62 (s, 6H), 1.24 (t, J = 7.12 Hz, 3H). 19 F NMR (471 MHz, CDCl3) δ -25.0 (s, 3F). 13 C NMR (126 MHz, CDCl3) δ 173.3, 153.4, 135.5, 129.5, 129.1, 116.5, 109.6, 104.6 (q, J = 353.4Hz), 81.4, 62.0, 25.3, 14.2.
[0065] Example 8
[0066] Step 1: Under nitrogen protection, aniracetam (1 mmol, 219.2 mg), thianthrene oxide (1 mmol, 232.3 mg) and acetonitrile (5 mL) were added to a 25 mL round-bottom flask in sequence and the temperature was lowered to -40 o C, trifluoroacetic anhydride (0.42 mL) and trifluoromethanesulfonic acid (0.26 mL) were added in sequence, and the mixture was stirred at -40 oC for 1 hour, then warm to room temperature for 12 hours. After the reaction is completed, dilute the reaction solution with DCM (20 mL), neutralize with saturated sodium bicarbonate aqueous solution (20 mL), wash the organic layer with water (20 mL) once, extract the water layer with DCM (20 mL) twice, combine the organic layers and wash twice with saturated sodium trifluoromethanesulfonate aqueous solution (20 mL), dry the organic phase with anhydrous sodium sulfate, and remove excess solvent under reduced pressure. The residue is recrystallized with a mixed solvent of dichloromethane and methyl tert-butyl ether (1:15, 50 mL) to obtain the corresponding thrombium salt (white solid, 424.5 mg, 73%).
[0067] Step 2: In a glove box, add aniracetam thianthrene salt (0.1 mmol, 58.4 mg), [Me4N][TeCF3] (0.14 mmol, 37.9 mg) and DMF (0.5 mL) to a 10 mL reaction tube. Remove the reaction tube from the glove box and place it under blue LED (450-495 nm, 5 W) for 12 hours. The reaction temperature is controlled at 0 o C. After the reaction, the product was separated and purified by silica gel column chromatography using petroleum ether / ethyl acetate (10:1) as eluent to obtain trifluoromethyltellurium-modified aniracetam molecule (light yellow oily liquid 31.0 mg, yield 75%). 1 H NMR (500MHz, CDCl3) δ 8.06 (d, J = 1.86 Hz, 1H), 7.71 (dd, J =8.58 Hz, J =2.05 Hz, 1H), 6.92 (d, J = 8.68 Hz, 1H), 3.96 (d, J =7.09 Hz, 2H), 3.93 (s, 3H), 2.62 (t, J = 8.01 Hz, 2H), 2.18-2.12 (m, 2H). 19 F NMR (471 MHz, CDCl3) δ -25.0 (s,3F). 13 C NMR (126 MHz, CDCl3) δ 174.7, 169.1, 162.0, 140.1, 133.3, 128.6,109.2, 103.6 (q, J = 354.8 Hz), 102.7, 56.6, 46.9, 33.5, 17.8.
[0068] Example 9
[0069] Step 1: Under nitrogen protection, add gemfibrozil methyl ester (1 mmol, 264.4 mg), thianthrene oxide (1.5 mmol, 348.5 mg) and acetonitrile (5 mL) into a 25 mL round-bottom flask in sequence and cool to -40 o C, trifluoroacetic anhydride (0.42 mL) and trifluoromethanesulfonic acid (0.26 mL) were added in sequence, and the mixture was stirred at -40 o C for 1 hour, then warm to room temperature for 12 hours. After the reaction is completed, dilute the reaction solution with DCM (20 mL), neutralize with saturated sodium bicarbonate aqueous solution (20 mL), wash the organic layer with water (20 mL) once, extract the water layer with DCM (20 mL) twice, combine the organic layers and wash twice with saturated sodium trifluoromethanesulfonate aqueous solution (20 mL), dry the organic phase with anhydrous sodium sulfate, and remove excess solvent under reduced pressure. The residue is recrystallized with a mixed solvent of dichloromethane and methyl tert-butyl ether (1:25, 50 mL) to obtain the corresponding thrombium salt (white solid, 405 mg, 68%).
[0070] Step 2: In a glove box, add gemfibrozil methyl thianthrene salt (0.1 mmol, 62.9 mg), [Me4N][TeCF3] (0.14 mmol, 37.9 mg) and DMF (0.5 mL) to a 10 mL reaction tube. Remove the reaction tube from the glove box and place it under green LED (520-570 nm, 5 W) for 12 hours. The reaction temperature is controlled at 30-32 o C. After the reaction, the product was separated and purified by silica gel column chromatography using petroleum ether / ethyl acetate (10:1) as the eluent to obtain trifluoromethyltellurium-modified gemfibrozil methyl ester molecule (light yellow oily liquid 30.8 mg, yield 67%). 1 H NMR (500 MHz, CDCl3) δ 7.84 (s, 1H), 6.80 (s, 1H), 3.95 (t, J =5.81 Hz,2H), 3.66 (s, 3H), 2.59 (s, 3H), 2.17 (s, 3H), 1.78-1.69 (m, 4H), 1.22 (s,6H). 19 F NMR (471 MHz, CDCl3) δ -25.9 (s, 3F).
[0071] Example 10
[0072] Step 1: Under nitrogen protection, biphenyl (1 mmol, 154.2 mg), thianthrene oxide (1 mmol, 232.3 mg) and DCM (20 mL) were added to a 25 mL round-bottom flask in sequence and the temperature was lowered to -40 o C, then trifluoromethanesulfonic anhydride (0.2 mL) was added, and the mixture was stirred at -40 o C for 1 hour, then warm to room temperature for 12 hours. After the reaction is completed, dilute the reaction solution with DCM (20 mL), neutralize with saturated sodium bicarbonate aqueous solution (20 mL), wash the organic layer with water (20 mL) once, extract the aqueous layer with DCM (20 mL) twice, combine the organic layers and dry with anhydrous sodium sulfate, and remove excess solvent under reduced pressure. The residue is recrystallized with a mixed solvent of dichloromethane and methyl tert-butyl ether (1:25, 50 mL) to obtain the corresponding thrombium salt (white solid, 466.7 mg, 90%).
[0073] Step 2: In a glove box, add biphenylthianthrene coronium salt (0.1 mmol, 51.8 mg), [Me4N][TeCF3] (0.14 mmol, 37.9 mg) and acetonitrile (0.5 mL) to a 10 mL reaction tube. Remove the reaction tube from the glove box and place it under green LED (520-570 nm, 5 W) for 8 hours. The reaction temperature is controlled at 30-32 o C. After the reaction, the product was separated and purified by silica gel column chromatography using petroleum ether as eluent to obtain trifluoromethyltellurium-modified biphenyl molecules (yellow oily liquid 15.2 mg, yield 43%). 1 H NMR (500 MHz, CDCl3) δ 8.07 (d,J = 8.14 Hz, 2H), 7.61-7.56 (m, 4H), 7.47 (t, J = 7.73 Hz, 2H), 7.39 (t, J =7.35 Hz, 1H). 19 F NMR (471 MHz, CDCl3) δ -25.4 (s, 3F). 13 C NMR (126 MHz, CDCl3)δ 143.3, 142.0, 140.1, 129.1, 128.7, 128.2, 127.4, 108.5, 102.8 (q, J = 353.5Hz).
[0074] Embodiment 11
[0075] Step 1: Under nitrogen protection, add boscalid (1 mmol, 343.2 mg), thianthrene oxide (1 mmol, 232.3 mg) and acetonitrile (5 mL) into a 25 mL round-bottom flask in sequence and cool to -40 o C, trifluoroacetic anhydride (0.42 mL) and trifluoromethanesulfonic acid (0.26 mL) were added in sequence, and the mixture was stirred at -40 o C for 1 hour, then warm to room temperature for 12 hours. After the reaction is completed, dilute the reaction solution with DCM (20 mL), neutralize with saturated sodium bicarbonate aqueous solution (20 mL), wash the organic layer with water (20 mL) once, extract the water layer with DCM (20 mL) twice, combine the organic layers and wash twice with saturated sodium trifluoromethanesulfonate aqueous solution (20 mL), dry the organic phase with anhydrous sodium sulfate, and remove excess solvent under reduced pressure. The residue is recrystallized with a mixed solvent of dichloromethane and methyl tert-butyl ether (1:25, 50 mL) to obtain the corresponding thrombium salt (white solid, 671 mg, 95%).
[0076] Step 2: In a glove box, add boscalid thianthrene salt (0.1 mmol, 70.8 mg), [Me4N][TeCF3] (0.14 mmol, 37.9 mg) and DMF (0.5 mL) to a 10 mL reaction tube. Remove the reaction tube from the glove box and place it under green LED (520-570 nm, 5 W) for 12 hours. The reaction temperature is controlled at 30-32 o C. After the reaction, the product was separated and purified by silica gel column chromatography using petroleum ether / ethyl acetate (2:1) as the eluent to obtain the trifluoromethyltelluryl-modified boscalid molecule (white solid 16.7 mg, yield 31%). 1 H NMR (500 MHz, CDCl3) δ 8.51 (d, J = 8.4 Hz, 1H), 8.45 (dd, J = 4.8 Hz, 1.7 Hz, 1H), 8.34(s, 1H), 8.16 (d, J = 7.4 Hz, 1H), 8.06 (d, J = 8.4 Hz, 1H), 7.89 (s, 1H), 7.46 (d, J = 8.3 Hz, 2H), 7.36-7.33 (m, 3H). 19 F NMR (471 MHz, CDCl3) δ -25.5(s, 3F).
[0077] In summary, it can be seen from Examples 1-11 that the method provided by the present invention can achieve trifluoromethyltellurylation of various types of bioactive molecules.
[0078] In other embodiments of the present invention, the following typical reaction products can also be obtained, and their preparation processes are no longer listed one by one: .
[0079] Experimental Group The bioactivity of the above synthesized trifluoromethyltellurium-containing molecules was evaluated using cervical cancer cell line Hela cells as model cells. The specific steps of the bioactivity test are as follows: Step 1: Rinse the culture dish with PBS, remove the PBS with a pipette, add 0.25% EDTA to digest for 2 minutes, remove the EDTA again, add 1 mL of culture solution, and prepare 2-3 mL of culture solution for use. Prepare a 96-well plate, and use PBS to isolate the outermost circle from the outside world to promote the growth of edge cells and reduce external influences. Select an area to add PBS as a blank control group, and divide the remaining area into five areas, add 100 μL of culture solution and different concentrations of drugs respectively, and then add cells to each grid except the outer one. Incubate the cells after plating for one day.
[0080] Step 2: Aspirate the original drug solution and wash twice with PBS. Add 10 μL of thiazolyl blue (MTT) DMSO solution (5 mg / mL) and 90 μL of culture medium to each well, and then incubate for 3 hours. Discard the culture medium, add 100 μL of DMSO to each well, wrap the culture dish with tin foil and newspaper, and place it on a shaker to mix for 10 minutes. Calculate the cell survival rate. Test results are shown in Figure 1-7 and Table 1.
[0081] Table 1
[0082] pass Figure 1-7 As can be seen from Table 1, the (hetero)aryl trifluoromethyl telluride ether compounds synthesized in the present invention have high inhibitory activity against Hela cells. Among them, trifluoromethyl telluride-modified aniracetam (Aniracetam-TeCF3) and boscalid-TeCF3 have the highest inhibitory activity against Hela cells. After co-culturing them with model cells for 1 day, the survival rate of Hela cells was tested, and the IC50 values were calculated to be 2.35±0.07 μmol / L and 8.18±0.05 μmol / L, respectively. It can be seen that the introduction of trifluoromethyl telluride into bioactive molecules has very important potential research value.
[0083] The specific implementation of the present invention described above does not constitute a limitation on the protection scope of the present invention. Any other corresponding changes and modifications made based on the technical concept of the present invention should be included in the protection scope of the claims of the present invention.
Claims
1. A method for preparing a (hetero)aryl trifluoromethyl telluride ether compound, characterized in that: The following steps are involved: The (hetero)aryl trifluoromethyl tellurium salt and the first solvent are reacted under light conditions, and after the reaction is completed, the (hetero)aryl trifluoromethyl tellurium ether compound is obtained by first separation and purification.
2. The method for preparing the (hetero)aryl trifluoromethyl tellurium ether compound according to claim 1, characterized in that: The (hetero)aryl coronium salt is one of a thianthrene coronium salt containing a (hetero)aryl group, a phenoxathiol coronium salt containing a (hetero)aryl group, a dibenzothiophene coronium salt containing a (hetero)aryl group, and a diphenyl coronium salt containing a (hetero)aryl group.
3. The method for preparing the (hetero)aryl trifluoromethyl tellurium ether compound according to claim 1, characterized in that: The (hetero)aryl coronium salt is a thianthrene coronium salt containing a (hetero)aryl group, and the preparation method of the thianthrene coronium salt containing a (hetero)aryl group comprises the following steps: The (hetero)aromatic hydrocarbon, thianthrene oxide, acid anhydride and optional acid are reacted in a second solvent, and after the reaction is completed, a second separation and purification is performed to obtain a thianthrene-based coronium salt containing a (hetero)aromatic group; wherein, The acid anhydride is at least one of trifluoromethanesulfonic anhydride or trifluoroacetic anhydride; and / or, The acid is trifluoromethanesulfonic acid; and / or, The second solvent is one of acetonitrile or dichloromethane; and / or, The molar ratio of the (hetero)aromatic hydrocarbon to the thianthrene oxide is 1:(0.1-10); and / or, The ratio of the (hetero)aromatic hydrocarbon to the total amount of the acid and the anhydride is (1-6) mol:1L; and / or, The usage ratio of the (hetero)aromatic hydrocarbon to the second solvent is (0.05-0.3) mol:1L.
4. The method for preparing the (hetero)aryl trifluoromethyl tellurium ether compound according to claim 3, characterized in that: The process of reacting (hetero)aromatic hydrocarbon, thianthrene oxide, acid anhydride and optional acid in a second solvent comprises: firstly reacting a mixture of (hetero)aromatic hydrocarbon, thianthrene oxide, a second solvent, acid anhydride and optional acid at -50 to -40 o C for 0.5-2 hours, then warm to room temperature for 8-24 hours.
5. The method for preparing the (hetero)aryl trifluoromethyl tellurium ether compound according to claim 3, characterized in that: The second separation and purification method includes at least one of extraction, washing, column chromatography, and recrystallization; wherein, The extractant is at least one of dichloromethane and acetonitrile; and / or, The washing comprises at least one of water washing or saturated sodium trifluoromethanesulfonate aqueous solution washing; and / or, The eluent used for the column chromatography is a mixed solvent of dichloromethane and acetonitrile, and the volume ratio of dichloromethane to acetonitrile is (1-5):1; and / or, The solvent used for the recrystallization is a mixed solvent of dichloromethane and methyl tert-butyl ether, and the volume ratio of dichloromethane to methyl tert-butyl ether is 1: (10-25).
6. The method for preparing the (hetero)aryl trifluoromethyl tellurium ether compound according to claim 1, characterized in that: The trifluoromethyl tellurium salt is [Me4N][TeCF3], [ n -Bu4N][TeCF3], [PNP][TeCF3] or [(dibenzo-18-crown-6)K][TeCF3]; and / or, The molar ratio of the (hetero)aryl coronium salt to the trifluoromethyltellurium salt is 1:(0.5-3); and / or, The first solvent is one of N,N-dimethylformamide, dimethyl carbonate, acetonitrile, N,N-dimethylacetamide, tetrahydrofuran, n-hexane, ethyl acetate, 1,2-dichloroethane, diethylene glycol dimethyl ether, ethyl ether, methyl tert-butyl ether, dichloromethane, N-methylpyrrolidone, 1,4-dioxane, hexafluoroisopropanol, benzene, toluene or xylene; and / or, The usage ratio of the (hetero)aryl stearium salt to the first solvent is (0.025-0.3) mol:1 L.
7. The method for preparing the (hetero)aryl trifluoromethyl tellurium ether compound according to claim 1, characterized in that: The wavelength of the light source used in the illumination conditions is 365-600 nm, the power is 5-50 W; the reaction temperature is -40 ~ 40 o C, the reaction time is 4-24 h; the reaction is carried out under a protective atmosphere.
8. The method for preparing the (hetero)aryl trifluoromethyl tellurium ether compound according to claim 1, characterized in that: The first separation and purification method includes: column chromatography; wherein, The eluent used for the column chromatography is at least one of petroleum ether and ethyl acetate.
9. Use of the method for preparing the (hetero)aryl trifluoromethyl telluride compound according to any one of claims 1 to 8 in preparing a drug having a (hetero)aryl trifluoromethyl telluride structure.
10. Use of the method for preparing a (hetero)aryl trifluoromethyl telluride compound according to claim 9 in preparing a drug having a (hetero)aryl trifluoromethyl telluride structure, characterized in that: The drug is an anticancer drug.
Citation Information
Patent Citations
Trifluoromethylation of trifluoromethyl aryl sulfonium salt to heterocyclic compound under metal trigger
CN101973829A
